Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TX-12-004-HR in Postmenopausal Women With VVA
NCT02449902Phase 2Completed
- Sponsor
- TherapeuticsMD
- Start
- Jul 2013
- Primary completion
- Sep 2013
- Modality
- Hormone, Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of estradiol in vulvovaginal atrophy (VVA), sponsored by TherapeuticsMD. Started Jul 2013; status: completed.
02
Drugs
estradiol
03
Conditions
vulvovaginal atrophy (VVA)
Beyond the preview
Go deeper on NCT02449902.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02449902.